Dr. Anusha Sivakumar received her PhD from Madurai Kamaraj University in India in 2019 where she investigated the role of mitochondrial structure-function relationship in the development and progression of cardiac diseases. During this period, she was supported by Junior Research Fellowship and Senior Research Fellowship from the Government of India. She then became a Senior Scientist in Research & Development at Thermo Fisher Inc., (India) from 2019 to 2021, where she worked on a commercial antibody validation program. In August 2021, Anusha started as a Post-Doctoral Fellow at the Cherqui Lab at the University of California, San Diego, to work on the neurodegenerative disease called Friedreich’s Ataxia (FA), primarily caused by mitochondrial dysfunction. In 2022, she became a Project Scientist & Project Manager, at the same lab, to support the bench-to-bedside translation of autologous hematopoietic stem and progenitor cell (HSPC) and CRISPR/Cas9 gene therapy for FA.